Global Lyme Alliance (GLA) officially opens its competition for the 2019-20 Lyme disease research grants applications today, July 15, 2019.
GLA has awarded nearly $12 million in grants to scientists at more than 40 academic institutions to study Lyme and other tick-borne diseases. Proposals are expected to be of high scientific quality from scientists and clinicians who use evidence-based, data-driven research to drive knowledge forward. GLA’s world-class Scientific Advisory Board rigorously evaluates all proposals in a process modeled after the National Institutes of Health Study Section Review Panel mechanism, to select projects of the highest scientific merit.
This year, GLA’s competition will begin with a Letter of Intent (LOI). Only applicants whose LOI is in programmatic alignment with GLA’s research priorities will be invited to submit a full proposal.
Priorities for this year’s projects include Lyme disease and Babesiosis. Priority will be given to proposals in Lyme disease, host immunology/immune dysregulation with an emphasis on pathogenesis, post-treatment Lyme disease, direct diagnostics and improved treatment. Molecular biology and bioinformatics-oriented proposals are also considered. Proposals focusing on improved treatment based on novel antimicrobials and drug combinations are encouraged. Proposals in Babesiosis should address critical needs in diagnostics, treatment, pathogenesis, and strain differences. Proposals exploring the basis for the emergence of antibiotic resistance will be considered.
Letters of Intent may be submitted July 15, 2019 through midnight on July 22, 2019.